Eledon Pharmaceuticals Inc (ELDN)
2.49
+1.43%
Eledon Pharmaceuticals Inc (ELDN) is currently trading at $2.49. This represents a gain of 1.43% from the previous session. With a market capitalization of $0.20B, ELDN is a key component of the Health Care sector. Investors looking to trade ELDN should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ELDN commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Eledon Pharmaceuticals Inc (ELDN) shows a bullish trend. Analysts are watching the 2.59 level closely.
Fundamentals
Mkt Cap0.20B
P/E Ratio0.0000
Volume563,166
60-Day Technical Chart
Advanced Charting
Need more indicators for ELDN? Use the world's #1 platform.
Open ELDN on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $2
| Metric |
ELDN +1.43% |
ASPN -25.00% |
ALLO +6.99% |
CCO +0.84% |
|---|---|---|---|---|
| Price | $2.49 | $2.67 | $2.46 | $2.39 |
| Mkt Cap | $0.20B | $0.22B | $0.55B | $1.19B |
| - | View → | View → | View → |
Latest Headlines
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) is largely controlled by institutional shareholders who own 51% of the company
Yahoo Finance • Oct 9, 2025
Eledon Pharma (NASDAQ: ELDN) prices $50M offering; adds 30-day underwriter option
Stock Titan • Nov 12, 2025
With 51% ownership in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), institutional investors have a lot riding on the business
simplywall.st • Oct 18, 2025
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
TipRanks • Nov 7, 2025
Eledon Pharmaceuticals stock tumbles after mixed kidney transplant data
Investing.com • Nov 7, 2025
● Gemini Agentic AI Analyst Insight for ELDN
Market Education
- Government Shutdowns: What They Mean for Wall Street Sep 26, 2025
- Stocks with Cash and Low Debt Dec 10, 2023
- 🔥 Top 7 AI Penny Stocks That Could Explode in 2025 Nov 16, 2025
External Research